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Materials and Methods: Between 1999 and 2006, 368 endometrial
cancer patients underwent surgical treatment in our hospital. These
patients were further categorized into low-risk (grade 1 and 2
endometrioid lesions with MI ≤ 50% and PTD≤2 cm) and high-risk
groups. The prognosis of the high risk group patients with complete
staging operation was analyzed.
Results: The majority of the patients were high-risk patients
(251/368, 68%). We then divided them into lymph node
(LN) negative and LN positive (either para-aortic or pelvic LN
positive) groups. The distant metastasis rate in LN negative group
was low (5/140, 3.6%), but was high in LN positive group (14/31,
45.2%). Among the LN positive group, distant metastasis rate for
pelvic LN positive only patients was 38.5%(5/13) and 50%(8/16) in
both para-aortic and pelvic LN positive patients. There were no
distant metastasis events noticed in our two patients with para-
aortic LN positive but pelvic LN negative.
Conclusion: In our hospital, para-aortic lymph node dissections
were performed up to the inferior mesenteric artery(IMA).
According to the report by Podratz et al., Routinely performing
lymphadenectomy(LD) only up to the IMA will potentially miss
38% to 46% of patients with positive para-aortic nodes. However,
the distant metastasis rate for LN negative patients in our study was
3.6%, which was much less than our expectation as in accordance
with Podratz’s report. Therefore, para-aortic LD to IMA level does
not under-stage endometrial cancer patients and does not miss
para-aortic LN in LN negative patients. Our results do not support
the routine need of high level para-aortic LD. High level para-arotic
LD should only be considered when intra-operative frozen section
for LN is sent and shows positive.
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Objective: To evaluate the accuracy of visual inspection with 5%
acetic acid (VIA) when used to detect cervical cancer and its
precursors.
Methods: The study population included women attended Family
Planning and Gynecological Clinic in Bagher Abad Health Center
and Mirza Koochak Khan Hospital for regular cervical screening
tests. After obtaining informed consent from each woman, VIA was
performed. One hundred with a positive VIA test and 100 women
with a negative VIA test were randomly selected for this study.
Cytology and colposcopy examination were performed for all 200
cases and cervical biopsies were conducted for those individuals
showing abnormal colposcopic findings.
Results: Nine cases in VIA-positive group and two cases in VIA-
negative group had an abnormal cytology. Ninety five women in the
VIA-positive group and 25 in the VIA-negative group had abnormal
colposcopic findings. From biopsy examination, 67 (71%) of cases
in the VIA-positive group and 3 (12%) cases in the VIA-negative
group had a final diagnosis of dysplasia. Among biopsied samples,
only 7 cases of VIA-positive group showed abnormal result and the
remaining were normal. Based on these results, VIA test sensitivity
and specificity were 95.7% and 44.0% respectively, while they were
10% and 92% for cytology tests.
Conclusions: The results of this study indicate that although VIA is
a sensitive screening test for detection of cervical dysplasia, it can
not be used by itself. Applying VIA along with Pap smears helps to
detect a higher number of cases with cancer precursor lesions.
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Alpha-fetoprotein-producing peritoneal malignant mixed
Mu¨llerian tumor
Y. Li1, T. Kuo. 1Kuo General Hospital, 2
Introduction: Malignant mixed Mu¨llerian tumor(MMMT), also
known as malignant mixed mesodermal tumors are rare.
An admixture of carcinomatous and sarcomatous components
characterizes MMMT. They usually arise in the endometrium, and
less commonly in the ovaries, fallopian tubes, cervix and vagina.
Rare examples of MMMT occurring extragenitally have also been
reported. Here, we present a patient with MMMT arising from
peritoneum along with alpha-fetoprotein production.
Case report: A 60-year-old, gravida 5, para 5, postmenopausal
female presented with abdominal fullness and lower abdominal
pain for 2 weeks duration. She had been well without using
hormone replacement therapy. A whole-body positron emission
tomography did not reveal any abnormality one month earlier in
another hospital. On admission, physical examination revealed a
large, firm, nontender mass in the pelvis and lower abdomen.
Ultrasonography revealed a solid tumor with mixed internal
components in the pelvis, measuring 15 cm in the largest
diameter. Computed tomography confirmed a large tumor in the
pelvis with ascites in the abdominal cavity. The serum markers
showed elevate in CA125 719.2U/ml, a-fetoprotein 271ng/ml, CEA
3.3 ng/ml, and lactate dehydrogenase (LDH) 819 IU/L. An exploratory
laparatomy revealed 2600ml of bloody ascitic fluid. A large
retroperitoneal tumor, which was well demarcated and about
15 cm in greatest dimension, extended to the posterior pelvic
wall. The uterus, ovaries and fallopian tubes were normal with
superficial lesions. A suboptimal extirpation of the retroperitoneal
tumor, total hysterectomy with bilateral salpingo-oophorectomy,
and omentectomy were performed. Histological examination
revealed peritoneal MMMT with omental involvement and a minor
component of yolk sac tumor. The patient recovered uneventfully
and has been closedly observed under the chemotherapy regimen
using paclitaxel and carboplatin for 3 courses, and lipodox and
cyclophosphamide for 2 courses. All tumor markers returned to
normal levels quickly. No signs and symptoms suggest of recurrence
or metastasis were noted 7 months postoperatively.
Discussion: Alpha-fetoprotein-producing peritoneal MMMT is a
rare malignancy. The prognosis of these patient is poor. Little is
known about their pathogenesis. However, surgical cytoreduction
and postoperative aggressive chemotherapy may have a favorable
outcome and appear indicated.
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Objectives: Endometrial cancer is one of the most common
malignancies of the female genital tract. The aim of this study
was to evaluate prognostic factors in relation to clinicopathologic
characterisrics and tumor markers.
Materials and Methods: In this study we examined 276patients
with endometrial cancer. Between January 1996 and December
2001, each of these patients underwent a hysterectomy, bilateral
salpingo-oophorectomy, pelvic and/or para-aortic lymphadenec-
tomy at the Department of Obstetrics and Gynecology of Nippon
Medical School or Department of Gynecology of Kanagawa Cancer
Center Hospital. The following factors were studied: pelvic lymph
node metastasis, histologic type, histologic grade, myometrial
invasion, lymphovascular space invasion, cervical invasion, ovarian
metastasis, positive ascites cytology, and preoperative CA125 values.
The survival rates were calculated by the Kaplan-Meier method,
and the differences between the survival curves were examined
